Using MRI to measure aerosol deposition

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 25, Issue 2, 2012, Pages 55-62

  Thompson, Richard B ^a   Finlay, Warren H ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

aerosol; contrast agent; lung deposition; magnetic resonance imaging; ventilation

Indexed keywords

GADOLINIUM PENTETATE; OXYGEN; PROTON;

AEROSOL; CARDIAC GATED IMAGING; ELECTROMAGNETIC FIELD; HUMAN; HYPERPOLARIZATION; IN VITRO STUDY; IN VIVO STUDY; LUNG DIFFUSION; LUNG VENTILATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN TENSION; QUANTUM MECHANICS; RADIATION; RELAXATION TIME; REVIEW; VOXEL BASED MORPHOMETRY;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; NEBULIZERS AND VAPORIZERS; PHARMACEUTICAL PREPARATIONS; RESPIRATORY SYSTEM; TISSUE DISTRIBUTION;

EID: 84859375130     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2011.0897     Document Type: Review

References (51)

1. Human respiratory tract model for radiological protection: a report of a Task Group of the International Commission on Radiological Protection. Ann ICRP. 1994;24:1-482.
2. Byron PR, Hindle M, Lange CF, Longest PW, McRobbie D, Oldham MJ, Olsson B, Thiel CG, Wachtel H, and Finlay WH: In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols. J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 2):S59-S69.
3. Scheuch G, Bennett W, Borgstrom L, Clark A, Dalby R, Dolovich M, Fleming J, Gehr P, Gonda I, OCallaghan C, Taylor G, and Newman S: Deposition, imaging, and clearance: what remains to be done? J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 2):S39-S57.
4. Martin AR, Thompson RB, and Finlay WH: MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles. J Aerosol Med Pulm Drug Deliv. 2008;21:335-342.
5. Redman GES, Martin AR, Waszak P, Thompson RB, Cheung PY, Thebaud B, and Finlay WH: Pilot study of inhaled aerosols targeted via magnetic alignment of high aspect ratio particles in rabbits. J Nanomater. 2011;2011:1-7.
6. Sood BG, Shen Y, Latif Z, Chen X, Sharp J, Neelavalli J, Joshi A, Slovis TL, and Haacke EM: Aerosol delivery in ventilated newborn pigs: an MRI evaluation. Pediatr Res. 2008;64:159-164.
7. Sood BG, Shen Y, Latif Z, Galli B, Dawe EJ, and Haacke EM: Effective aerosol delivery during high-frequency ventilation in neonatal pigs. Respirology. 2010;15:551-555.
8. Darquenne C, Oakes JM, Breen EC, and Scadeng M: Quantification of aerosol deposition in healthy and emphysematous rat lung using MRI. Proceedings of the International Society for Aerosols in Medicine Congress, Rotterdam, NL, June 18-22, 2011.
9. Sarracanie M, Grebenkov D, Sandeau J, Coulibaly S, Martin AR, Hill K, Sanchez JMP, Fodil R, Martin L, Durand E, Caillibotte G, Isabey D, Darrasse L, Bittoun J, and Maitre X: Aerosol deposition in a mouth-throat cast measured by hyperpolarized helium-3 MRI compared to spect measurement. and numerical simulation. Proceedings of the International Society for Aerosols in Medicine Congress, Rotterdam, NL, June 18-22, 2011.
10. Bloch F: Nuclear induction. Phys Rev. 1946;70:460-474.
11. Benoit-Cattin H, Collewet G, Belaroussi B, Saint-Jalmes H, and Odet C: The SIMRI project: a versatile and interactive MRI simulator. J Magn Reson 2005;173:97-115.
12. Goodson BM: Nuclear magnetic resonance of laser-polarized noble gases in molecules, materials, and organisms. J Magn Reson. 2002;155:157-216.
13. Moller HE, Chen XJ, Saam B, Hagspiel KD, Johnson GA, Altes TA, de Lange EE, and Kauczor HU: MRI of the lungs using hyperpolarized noble gases. Magn Reson Med. 2002;47:1029-1051.
14. Taratula O, and Dmochowski IJ: Functionalized 129Xe contrast agents for magnetic resonance imaging. Curr Opin Chem Biol. 2010;14:97-104.
15. Mosbah K, Ruiz-Cabello J, Berthezene Y, and Cremillieux Y: Aerosols and gaseous contrast agents for magnetic resonance imaging of the lung. Contrast Media Mol Imaging. 2008;3:173-190.
16. Ebert M, Grossmann T, Heil W, Otten WE, Surkau R, Leduc M, Bachert P, Knopp MV, Schad LR, and Thelen M: Nuclear magnetic resonance imaging with hyperpolarised helium-3. Lancet. 1996;347:1297-1299.
17. MacFall JR, Charles HC, Black RD, Middleton H, Swartz JC, Saam B, Driehuys B, Erickson C, Happer W, Cates GD, Johnson GA, and Ravin CE: Human lung air spaces: potential for MR imaging with hyperpolarized He-3. Radiology. 1996;200:553-558.
18. Deninger AJ, Eberle B, Ebert M, Grossmann T, Hanisch G, Heil W, Kauczor HU, Markstaller K, Otten E, Schreiber W, Surkau R, and Weiler N: (3)he-MRI-based measurements of intrapulmonary p(O2) and its time course during apnea in healthy volunteers: first results, reproducibility, and technical limitations. NMR Biomed. 2000;13:194-201.
19. Deninger AJ, Eberle B, Bermuth J, Escat B, Markstaller K, Schmiedeskamp J, Schreiber WG, Surkau R, Otten E, and Kauczor HU: Assessment of a single-acquisition imaging sequence for oxygen-sensitive (3)He-MRI. Magn Reson Med. 2002;47:105-114.
20. Wild JM, Fichele S, Woodhouse N, Paley MN, Kasuboski L, and van Beek EJ: 3D volume-localized pO2 measurement in the human lung with 3He MRI. Magn Reson Med. 2005;53: 1055-1064.
21. Yablonskiy DA, Sukstanskii AL, Leawoods JC, Gierada DS, Bretthorst GL, Lefrak SS, Cooper JD, and Conradi MS: Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI. Proc Natl Acad Sci USA. 2002;99:3111-3116.
22. Parraga G, Ouriadov A, Evans A, McKay S, Lam WW, Fenster A, Etemad-Rezai R, McCormack D, and Santyr G: Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Invest Radiol. 2007;42:384-391.
23. Chen XJ, Moller HE, Chawla MS, Cofer GP, Driehuys B, Hedlund LW, and Johnson GA: Spatially resolved measurements of hyperpolarized gas properties in the lung in vivo. Part I: diffusion coefficient. Magn Reson Med. 1999;42:721-728.
24. Dimitrov IE, Charagundla SR, Rizi R, Reddy R, and Leigh JS: An MR imaging method for simultaneous measurement of gaseous diffusion constant and longitudinal relaxation time. Magn Reson Imaging. 1999;17:267-273.
25. Yablonskiy DA, Sukstanskii AL, Woods JC, Gierada DS, Quirk JD, Hogg JC, Cooper JD, and Conradi MS: Quantification of lung microstructure with hyperpolarized 3He diffusion MRI. J Appl Physiol. 2009;107:1258-1265.
26. de Rochefort L, Maitre X, Fodil R, Vial L, Louis B, Isabey D, Croce C, Darrasse L, Apiou G, Caillibotte G, Bittoun J, and Durand E: Phase-contrast velocimetry with hyperpolarized 3He for in vitro and in vivo characterization of airflow. Magn Reson Med. 2006;55:1318-1325.
27. de Rochefort L, Liu T, Kressler B, Liu J, Spincemaille P, Lebon V, Wu J, and Wang Y: Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: validation and application to brain imaging. Magn Reson Med. 2010;63:194-206.
28. Kouzes RT: The 3He suppy problem. A technical report prepared for the U.S. Department of Energy. Available at: reports/PNNL-18388.pdf, 2009
29. Bergin CJ, Glover GM, and Pauly J: Magnetic resonance imaging of lung parenchyma. J Thorac Imaging. 1993;8:12-17.
30. Hatabu H, Gaa J, Tadamura E, Edinburgh KJ, Stock KW, Garpestad E, and Edelman RR: MR imaging of pulmonary parenchyma with a half-Fourier single-shot turbo spin-echo (HASTE) sequence. Eur J Radiol. 1999;29:152-159.
31. Kauczor HU, and Kreitner KF: MRI of the pulmonary parenchyma. Eur Radiol. 1999;9:1755-1764.
32. Mayo JR, MacKay A, and Muller NL: MR imaging of the lungs: value of short TE spin-echo pulse sequences. AJR Am J Roentgenol. 1992;159:951-956.
33. Bauman G, Puderbach M, Deimling M, Jellus V, Chefdhotel C, Dinkel J, Hintze C, Kauczor HU, and Schad LR: Noncontrast- enhanced perfusion and ventilation assessment of the human lung by means of fourier decomposition in proton MRI. Magn Reson Med. 2009;62:656-664.
34. Zapke M, Topf HG, Zenker M, Kuth R, Deimling M, Kreisler P, Rauh M, Chefdhotel C, Geiger B, and Rupprecht T: Magnetic resonance lung function-a breakthrough for lung imaging and functional assessment? A phantom study and clinical trial. Respir Res. 2006;7:106.
35. Mai VM, Tutton S, Prasad PV, Chen Q, Li W, Chen C, Liu B, Polzin J, Kurucay S, and Edelman RR: Computing oxygenenhanced ventilation maps using correlation analysis. Magn Reson Med. 2003;49:591-594.
36. Mai VM, Liu B, Li W, Polzin J, Kurucay S, Chen Q, and Edelman RR: Influence of oxygen flow rate on signal and T(1) changes in oxygen-enhanced ventilation imaging. J Magn Reson Imaging. 2002;16:37-41.
37. Stock KW, Chen Q, Morrin M, Hatabu H, and Edelman RR: Oxygen-enhanced magnetic resonance ventilation imaging of the human lung at 0.2 and 1.5 T. J Magn Reson Imaging. 1999;9:838-841.
38. Edelman RR, Hatabu H, Tadamura E, Li W, and Prasad PV: Noninvasive assessment of regional ventilation in the human lung using oxygen-enhanced magnetic resonance imaging. Nat Med. 1996;2:1236-1239.
39. Hatabu H, Tadamura E, Chen Q, Stock KW, Li W, Prasad PV, and Edelman RR: Pulmonary ventilation: dynamic MRI with inhalation of molecular oxygen. Eur J Radiol. 2001;37:172-178.
40. Montgomery AB, Paajanen H, Brasch RC, and Murray JF: Aerosolized gadolinium-DTPA enhances the magnetic resonance signal of extravascular lung water. Invest Radiol. 1987;22:377-381.
41. Berthezene Y, Vexler V, Clement O, Muhler A, Moseley ME, and Brasch RC: Contrast-enhanced MR imaging of the lung: assessments of ventilation and perfusion. Radiology. 1992;183:667-672.
42. Berthezene Y, Muhler A, Lang P, Shames DM, Clement O, Rosenau W, Kuwatsuru R, and Brasch RC: Safety aspects and pharmacokinetics of inhaled aerosolized gadolinium. J Magn Reson Imaging. 1993;3:125-130.
43. Haage P, Adam G, Karaagac S, Pfeffer J, Glowinski A, Dohmen S, and Gunther RW: Mechanical delivery of aerosolized gadolinium-DTPA for pulmonary ventilation assessment in MR imaging. Invest Radiol. 2001;36:240-243.
44. Suga K, Ogasawara N, Okada M, Matsunaga N, and Arai M: Regional lung functional impairment in acute airway obstruction and pulmonary embolic dog models assessed with gadolinium-based aerosol ventilation and perfusion magnetic resonance imaging. Invest Radiol. 2002;37:281-291.
45. Suga K, Ogasawara N, Tsukuda T, and Matsunaga N: Assessment of regional lung ventilation in dog lungs with Gd-DTPA aerosol ventilation MR imaging. Acta Radiol. 2002;43:282-291.
46. Ogasawara N, Suga K, Kawakami Y, Yamashita T, Zaki M, and Matsunaga N: Assessment of regional lung function impairment in airway obstruction and pulmonary embolic dogs with combined noncontrast electrocardiogram-gated perfusion and gadolinium diethylenetriaminepentaacetic acid aerosol magnetic resonance images. J Magn Reson Imaging. 2004;20:46-55.
47. Misselwitz B, Muhler A, Heinzelmann I, Bock JC, and Weinmann HJ: Magnetic resonance imaging of pulmonary ventilation. Initial experiences with a gadolinium-DTPAbased aerosol. Invest Radiol. 1997;32:797-801.
48. Haage P, Karaagac S, Spuntrup E, Truong HT, Schmidt T, and Gunther RW: Feasibility of pulmonary ventilation visualization with aerosolized magnetic resonance contrast media. Invest Radiol. 2005;40:85-88.
49. Okuhata Y, Xia T, and Urahashi S: Inhalation MR lymphography: a new method for selective enhancement of the lung hilar and mediastinal lymph nodes. Magn Reson Imaging. 1994;12:1135-1138.
50. Stadler A, Jakob PM, Griswold M, Barth M, and Bankier AA: T1 mapping of the entire lung parenchyma: influence of the respiratory phase in healthy individuals. J Magn Reson Imaging. 2005;21:759-764.
51. Hopkins SR, and Prisk GK: Lung perfusion measured using magnetic resonance imaging: New tools for physiological insights into the pulmonary circulation. J Magn Reson Imaging. 2010;32:1287-1301.